Which has grown faster, CRL or TDOC?

Over the past five years, TDOC grew revenue faster — CRL at a 5.77% CAGR versus TDOC at 12.97%.

Which has been the better investment, CRL or TDOC?

Over the past 10-year, CRL delivered the higher annualized total return — CRL at 8.10% versus TDOC at -5.16%. Past performance doesn't predict future results.

Charles River Laboratories International, Inc. (CRL) vs Teladoc Health, Inc. (TDOC)

TDOC leads on 7 of 12 compared metrics.

A side-by-side comparison of Charles River Laboratories International, Inc. and Teladoc Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 23, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

CRL

Charles River Laboratories International, Inc.

Total return — CRL vs TDOC

growth of $100 · last 11y

CRL +158.1%TDOC -60.1%CRL compounded faster

Log scale — wide-divergence pair

CRL TDOC

CRL vs TDOC: by the numbers

•CRL is the larger company ($8.75B vs $1.37B market cap).
•Both run net losses; CRL's is the smaller (-4.59% vs -6.81% net margin).
•TDOC grew revenue faster over the past five years (12.97% vs 5.77% CAGR).

Which is better, CRL or TDOC?

Metric tally: CRL 5 · TDOC 7

It depends on what you're optimizing for:

GrowthTDOC(faster 5Y revenue CAGR)

QualityCRL(higher ROIC)

Metrics side by side

Valuation

Metric	CRL	TDOC
Forward P/E	14.73	—
P/S ratio	2.21	0.54●
P/B ratio	3.02	1.02●
EV / EBITDA	40.45	28.70●
FCF yield	4.40%	18.48%●

Profitability

Metric	CRL	TDOC
Gross margin	31.86%	65.62%●
Operating margin	11.77%●	-7.60%
Net margin	-4.59%●	-6.81%
ROE	-6.28%●	-12.81%
ROIC	8.36%●	-8.26%

Growth (annualized)

Metric	CRL	TDOC
Revenue CAGR (5Y)	5.77%	12.97%●
EPS CAGR (5Y)	-40.99%	—
FCF CAGR (5Y)	-3.98%	29.46%●
Total return CAGR (5Y)	-12.99%●	-45.50%

Frequently asked

Which is better, CRL or TDOC?: It depends on your goal. growth: TDOC (faster 5Y revenue CAGR); quality: CRL (higher ROIC). Across all compared metrics, TDOC leads 7 to 5.
Which has grown faster, CRL or TDOC?: Over the past five years, TDOC grew revenue faster — CRL at a 5.77% CAGR versus TDOC at 12.97%.
Which has been the better investment, CRL or TDOC?: Over the past 10-year, CRL delivered the higher annualized total return — CRL at 8.10% versus TDOC at -5.16%. Past performance doesn't predict future results.

Go deeper

Full CRL analysis Full TDOC analysis Interactive comparison tool

Dig into the metrics

Charles River Laboratories International P/E ratio Teladoc Health P/E ratio Charles River Laboratories International dividend yield Teladoc Health dividend yield Charles River Laboratories International ROE Teladoc Health ROE Charles River Laboratories International operating margin Teladoc Health operating margin Charles River Laboratories International revenue growth Teladoc Health revenue growth Charles River Laboratories International free cash flow Teladoc Health free cash flow

Charles River Laboratories International & Teladoc Health appear in these rankings

Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 23, 2026.